A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.

TRIAL REGISTRATION:PEP Study: Ethics committee N° 393/2004, EudraCT 2004-004209-98. PEP-X Study: Ethics committee amendment application N° 154/01/2008. ClinicalTrials.gov NCT03751332.

Bibliographic Details
Main Authors: Markus Riegersperger, Max Plischke, Anita Jallitsch-Halper, Corinna Steinhauser, Manuela Födinger, Wolfgang C Winkelmayer, Daniela Dunkler, Gere Sunder-Plassmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0218709

Internet

https://doi.org/10.1371/journal.pone.0218709

Similar Items